Literature DB >> 11238766

Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men.

A Wolk1, M Furuheim, B Vessby.   

Abstract

The fatty acid intake is in part reflected by the fatty acid composition of adipose tissue and serum lipids. We evaluated whether the proportions of myristic (14:0), pentadecanoic (15:0) and heptadecanoic (17:0) fatty acids in the adipose tissue triacylglycerols and serum cholesterol esters and phospholipids reflect long-term dairy fat consumption in free-living men. In 114 healthy men aged 40-76 y, we compared the relative content of 14:0, 15:0 and 17:0 in subcutaneous adipose tissue and in serum lipids with relative intake (g/100 g of total fat) assessed by two 1-wk weighed food records made 6 mo apart and assessed by fourteen 24-h dietary recall interviews equally distributed during 1 y. According to food records, the mean +/- SD dairy fat intake was 24.9 +/- 13.1 g/d (29.6 +/- 10.5 g/100 g total fat); intake of 14:0, 15:0 and 17:0 was 4.6, 0.23 and 0.16 g/100 g total fat, and the content in adipose tissue was 3.6, 0.36 and 0.25 g/100 g fatty acids, respectively. Pearson correlation coefficients between intake of dairy fat (based on 24-h recalls) and fatty acid composition of adipose tissue were 0.64 (P: < 0.001) for 14:0, 0.74 (P: < 0.001) for 15:0 and 0.60 (P: < 0.001) for 15:0 + 17:0. Corresponding correlations with serum cholesterol esters were 0.34 (P: < 0.001) (14:0), 0.45 (P: < 0.001) (15:0) and 0.56 (P: < 0.001) (15:0 + 17:0), and with serum phospholipids the values were 0.30 (P: < 0.01) (14:0), 0.50 (P: < 0.001) (15:0) and 0.50 (P: < 0.001) (15:0 plus 17:0). In our study population, the relative content of 15:0 or 14:0 in adipose tissue is a valid biomarker for long-term dairy fat intake in free-living individuals. When adipose tissue is not available, 15:0 content in serum cholesterol esters or phospholipids might be used. Intake data based on repeated 24-h recalls are equally informative and may be an equivalent choice in nutritional studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238766     DOI: 10.1093/jn/131.3.828

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  68 in total

Review 1.  Infant and childhood diet and type 1 diabetes risk: recent advances and prospects.

Authors:  Jill M Norris
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

2.  Plasma fatty acids as predictors of glycaemia and type 2 diabetes.

Authors:  Maria A Lankinen; Alena Stančáková; Matti Uusitupa; Jyrki Ågren; Jussi Pihlajamäki; Johanna Kuusisto; Ursula Schwab; Markku Laakso
Journal:  Diabetologia       Date:  2015-08-16       Impact factor: 10.122

3.  Fatty acids in serum and diet--a canonical correlation analysis among toddlers.

Authors:  Liisa Uusitalo; Jaakko Nevalainen; Irma Salminen; Marja-Leena Ovaskainen; Carina Kronberg-Kippilä; Suvi Ahonen; Sari Niinistö; Georg Alfthan; Olli Simell; Jorma Ilonen; Riitta Veijola; Mikael Knip; Suvi M Virtanen
Journal:  Matern Child Nutr       Date:  2011-11-08       Impact factor: 3.092

Review 4.  Biomarkers in nutritional epidemiology: applications, needs and new horizons.

Authors:  Mazda Jenab; Nadia Slimani; Magda Bictash; Pietro Ferrari; Sheila A Bingham
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

5.  Cross-sectional associations of food consumption with plasma fatty acid composition and estimated desaturase activities in Finnish children.

Authors:  Taisa Venäläinen; Ursula Schwab; Jyrki Ågren; Vanessa de Mello; Virpi Lindi; Aino-Maija Eloranta; Sanna Kiiskinen; David Laaksonen; Timo A Lakka
Journal:  Lipids       Date:  2014-05       Impact factor: 1.880

6.  The elongation of very long-chain fatty acid 6 gene product catalyses elongation of n-13 : 0 and n-15 : 0 odd-chain SFA in human cells.

Authors:  Zhen Wang; Dong Hao Wang; Yuliya Goykhman; Yuanyuan Yan; Peter Lawrence; Kumar S D Kothapalli; J Thomas Brenna
Journal:  Br J Nutr       Date:  2019-01-03       Impact factor: 3.718

7.  A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.

Authors:  Yu-Han Chiu; Kimberly A Bertrand; Shumin Zhang; Francine Laden; Mara M Epstein; Bernard A Rosner; Stephanie Chiuve; Hannia Campos; Edward L Giovannucci; Jorge E Chavarro; Brenda M Birmann
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

8.  Variability in associations of phosphatidylcholine molecular species with metabolic syndrome in Mexican-American families.

Authors:  Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Christopher K Barlow; Jeremy B Jowett; Claire Bellis; Thomas D Dyer; Matthew P Johnson; David L Rainwater; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; John Blangero; Joanne E Curran
Journal:  Lipids       Date:  2013-03-14       Impact factor: 1.880

Review 9.  The complex and important cellular and metabolic functions of saturated fatty acids.

Authors:  Philippe Legrand; Vincent Rioux
Journal:  Lipids       Date:  2010-07-13       Impact factor: 1.880

10.  Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Ann-Charlotte Elkan; Niclas Håkansson; Johan Frostegård; Tommy Cederholm; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.